Burcu Çalışkan

8PUBLICATIONS
27CO-AUTHORS
Biologically active moleculesBiomolecular modelling and designMolecular medicineMolecular targetsSocial epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 03, 2026
Biotinylated Diaryl Isoxazole Derivatives with Enhanced Janus Kinase 1 Inhibitory, Antiproliferative, and Apoptotic Activities in Cancer Cells.

|Jan 16, 2025
2-Phenylbenzothiazoles featuring heteroaryl sulfonamide end-capping substructures as developable mPGES-1 inhibitors.

Tansu Yalçın, Paul M Jordan, Abdurrahman Olğaç

|Dec 02, 2024
Novel Benzimidazole Derivatives as Potent Inhibitors of Microsomal Prostaglandin E2 Synthase 1 for the Potential Treatment of Inflammation, Pain, and Fever.

Azize Gizem Ergül, Paul M Jordan, Philipp Dahlke

|Feb 06, 2024
Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer.

Mustafa Emre Gedik, Ozge Saatci, Nathaniel Oberholtzer

|Jan 23, 2023
Benzoxazolone-5-Urea Derivatives as Human Soluble Epoxide Hydrolase (sEH) Inhibitors.

Tugce Gur Maz, Beyzanur Koc, Paul M Jordan

|Oct 24, 2022
Quinazoline-4(3H)-one-7-carboxamide Derivatives as Human Soluble Epoxide Hydrolase Inhibitors with Developable 5-Lipoxygenase Activating Protein Inhibition.

Sümeyye Turanlı, Azize Gizem Ergül, Paul M Jordan

Pageof 2

Frequent Collaborators

8 joint publications

Erden Banoglu

4 joint publications

Oliver Werz

3 joint publications

Kubra Ibis

3 joint publications

Tugce Gur Maz